This is the authors' abstract. We don't add key points for this paper.
Fabry disease is a rare, hereditary disease characterized by a deficiency of an enzyme, α galactosidase A (α gal A), responsible for progressive damage to many organs, leading to various symptomsn, Ocular damage, particularly to the cornea, is sometimes a precious element helping the positive diagnosis of the disease.We report the case of a 40-year-old patient diagnosed with Fabry disease, with bilateral conjunctival vascular toruosities, a "cornea verticillata and a peripheral cortical cataract.Better knowledge of ophthalmological signs, allows better screening and can participate in the evaluation of the effectiveness of substitute therapy.
No takes yet. Share an insight, caveat, or question.
Khamaily et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: